Authors: Scatton, B Cohen, C Perrault, G Oblin, A Claustre, Y Schoemaker, H Sanger, DJ Rouquier, L Porsolt, R

Citation: B. Scatton et al., The preclinical pharmacologic profile of tiapride, EUR PSYCHIA, 16, 2001, pp. 29S-34S

Authors: Griebel, G Perrault, G Simiand, J Cohen, C Granger, P Decobert, M Francon, D Avenet, P Depoortere, H Tan, S Oblin, A Schoemaker, H Evanno, Y Sevrin, M George, P Scatton, B

Citation: G. Griebel et al., SL651498: An anxioselective compound with functional selectivity for alpha(2)- and alpha(3)-containing gamma-aminobutyric acid(A) (GABA(A)) receptors, J PHARM EXP, 298(2), 2001, pp. 753-768

Authors: Ruano, D Letang, V Biton, B Avenet, P Benavides, J Scatton, B Vitorica, J

Citation: D. Ruano et al., Subunit composition of rat ventral spinal cord GABA(A) receptors, assessedby single cell RT-multiplex PCR, NEUROREPORT, 11(14), 2000, pp. 3169-3173

Authors: Scatton, B Sanger, DJ

Citation: B. Scatton et Dj. Sanger, Pharmacological and molecular targets in the search for novel antipsychotics, BEHAV PHARM, 11(3-4), 2000, pp. 243-256

Authors: Kapin, MA Doshi, R Scatton, B DeSantis, L Chandler, ML

Citation: Ma. Kapin et al., Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia, INV OPHTH V, 40(6), 1999, pp. 1177-1182

Authors: Curet, O Damoiseau-Ovens, G Sauvage, C Sontag, N Avenet, P Depoortere, H Caille, D Bergis, O Scatton, B

Citation: O. Curet et al., Preclinical profile of befloxatone, a new reversible MAO-A inhibitor, J AFFECT D, 51(3), 1998, pp. 287-303